AstraZeneca PLC
AZN
ISIN null / Valor 163523
AstraZeneca PLC
UMushroom community rating:
About company
AstraZeneca PLC is a global pharmaceutical company engaged in the discovery, development, and commercialization of prescription medicines across various therapy areas, including oncology, cardiovascular, renal, metabolism, respiratory, and immunology. The company emphasizes a science-led approach to healthcare, aiming to deliver innovative medicines that address significant unmet medical needs. AstraZeneca operates with a focus on three strategic priorities: advancing the science and innovation behind their therapies, driving growth and leadership in their chosen therapy areas, and promoting sustainability and ethical practices within their operations. The company's research and development efforts are geared towards creating next-generation therapeutics, leveraging advancements in biologics, nucleotide-based therapies, and cell therapies. AstraZeneca's business model is structured to facilitate accelerated decision-making and the rapid introduction of new medicines, with a significant commitment to improving patient access to their treatments globally.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
Performance
Volatility
282199 M
Market cap (USD)
7,402,348
Daily traded volume (Shares)
66.11 / 65.33
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
Karthika V
Alexander M. Huber
EQUITIES OF THE SAME SECTOR
